These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21880098)

  • 1. Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting.
    Kronenberg A; Koenig S; Droz S; Mühlemann K
    Clin Microbiol Infect; 2011 Dec; 17(12):1845-51. PubMed ID: 21880098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
    Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
    Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey.
    Yilmaz N; Agus N; Yurtsever SG; Pullukcu H; Gulay Z; Coskuner A; Kose S; Aydemir S; Gulenc N; Ozgenc O
    Med Sci Monit; 2009 Nov; 15(11):PI61-5. PubMed ID: 19865064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
    Kahlmeter G; Poulsen HO
    Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTX-M-15 in Uppsala County.
    Lindbäck H; Lindbäck J; Sylvan S; Melhus A
    Scand J Infect Dis; 2010 Apr; 42(4):243-8. PubMed ID: 20085420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
    Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
    Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
    Borsari AG; Bucher B; Brazzola P; Simonetti GD; Dolina M; Bianchetti MG
    Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
    J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010.
    Hoban DJ; Nicolle LE; Hawser S; Bouchillon S; Badal R
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):507-11. PubMed ID: 21767706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes.
    Ho PL; Wong RC; Yip KS; Loke SL; Leung MS; Mak GC; Chow FK; Tsang KW; Que TL;
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):439-45. PubMed ID: 17888610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece.
    Falagas ME; Polemis M; Alexiou VG; Marini-Mastrogiannaki A; Kremastinou J; Vatopoulos AC
    Med Sci Monit; 2008 Feb; 14(2):CR75-79. PubMed ID: 18227764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005).
    Nys S; Terporten PH; Hoogkamp-Korstanje JA; Stobberingh EE;
    J Antimicrob Chemother; 2008 Jul; 62(1):126-32. PubMed ID: 18417487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.
    Gobernado M; Valdés L; Alós JI; Garcia-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Jun; 20(2):206-10. PubMed ID: 17893757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
    Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
    J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.